semaglutide eye issues A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic anterior How to Avoid Ozempic Face

Semaglutide uses much lower doses (0.25mg to 2.4mg), requiring different concentrations

Our medical team provides detailed dosing instructions tailored to your specific digestive health needs and monitors your response

average body-weight loss with semaglutide STEP-1 trial (NEJM) average body-weight loss with tirzepatide SURMOUNT-1 trial (NEJM) lower risk of major heart events SELECT trial (NEJM) Figures are from peer-reviewed clinical trials of the active ingredients (semaglutide and tirzepatide), not a guarantee of individual results

AREAS The fat-dissolving injections can be used to target various areas, including the face, chin, arms, bra line, hips, stomach and thighs